Triple
T19906575
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Rous-Whipple Award |
E478433
|
entity |
| Predicate | namedAfter |
P63
|
FINISHED |
| Object | Francis Peyton Rous |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Francis Peyton Rous | Statement: [Rous-Whipple Award, namedAfter, Francis Peyton Rous]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Francis Peyton Rous Context triple: [Rous-Whipple Award, namedAfter, Francis Peyton Rous]
-
A.
Renato Dulbecco
Renato Dulbecco was an Italian virologist and Nobel Prize laureate renowned for his pioneering work on the interaction between viruses and the genetic material of cells, which advanced the understanding of cancer.
-
B.
Oswald Avery
Oswald Avery was a Canadian-American physician and molecular biologist best known for demonstrating that DNA is the material responsible for heredity.
-
C.
Hideyo Noguchi
Hideyo Noguchi was a prominent Japanese bacteriologist renowned for his research on infectious diseases, including syphilis and yellow fever, during his career at the Rockefeller Institute in the early 20th century.
-
D.
George H. Hitchings
George H. Hitchings was an American biochemist and pharmacologist who pioneered the development of important chemotherapy and antiviral drugs, work for which he shared the Nobel Prize in Physiology or Medicine.
-
E.
Emil Adolf von Behring
Emil Adolf von Behring was a German physiologist and immunologist renowned for developing serum therapy against diphtheria and tetanus, earning him the inaugural Nobel Prize in Physiology or Medicine.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Francis Peyton Rous Target entity description: Francis Peyton Rous was an American pathologist and Nobel laureate best known for discovering tumor-inducing viruses, fundamentally advancing cancer research.
-
A.
Renato Dulbecco
Renato Dulbecco was an Italian virologist and Nobel Prize laureate renowned for his pioneering work on the interaction between viruses and the genetic material of cells, which advanced the understanding of cancer.
-
B.
Oswald Avery
Oswald Avery was a Canadian-American physician and molecular biologist best known for demonstrating that DNA is the material responsible for heredity.
-
C.
Hideyo Noguchi
Hideyo Noguchi was a prominent Japanese bacteriologist renowned for his research on infectious diseases, including syphilis and yellow fever, during his career at the Rockefeller Institute in the early 20th century.
-
D.
George H. Hitchings
George H. Hitchings was an American biochemist and pharmacologist who pioneered the development of important chemotherapy and antiviral drugs, work for which he shared the Nobel Prize in Physiology or Medicine.
-
E.
Emil Adolf von Behring
Emil Adolf von Behring was a German physiologist and immunologist renowned for developing serum therapy against diphtheria and tetanus, earning him the inaugural Nobel Prize in Physiology or Medicine.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8e520682081909892916424699bd5 |
completed | April 10, 2026, 11:55 a.m. |
| NER | Named-entity recognition | batch_69e65946916881909c3f52208c07aa64 |
completed | April 20, 2026, 4:50 p.m. |
Created at: April 10, 2026, 1:52 p.m.